Table 4.
Association of CYP4F2, APOE and CYP2A6 SNPs with variability on warfarin required doses
Gene | SNP ID | Genotype | Initiation dose | Overall P-value* | Maintenance dose | Overall P-value* |
---|---|---|---|---|---|---|
CC | 35.87 [15.45] | 36.66 [17.11] | ||||
CYP4F2 | rs2108622 | CT | 38.22 [14.67] | 0.21 | 40.24 [19.99] | 0.54 |
TT | 44.59 [49.83] | 39.43 [12.76] | ||||
CC | 36.79 [14.33] | 38.24 [17.24] | ||||
APOE | rs74125 | TC | 53.39 [62.10] | 0.02 | 38.60 [25.09] | 0.48 |
TT | 38.40 […….] | |||||
GG | 38.13 [37.72] | 35.49 [17.74] | ||||
APOE | rs405509 | GT | 38.28 [15.55] | 0.98 | 41.01 [18.36] | 0.30 |
TT | 37.60 [14.39] | 37.98 [17.04] | ||||
CYP2A6 | rs1801272 | AA | 38.16 [22.83] | 0.67 | 38.56 [16.79] | 0.99 |
TA | 33.64 [34.87] | 38.60 [45.86] |
*One-way ANOVA test with P-value < 0.05 is considered significant, Mean Standard deviation in square brackets.